Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?

Annals of the Rheumatic Diseases

Volumn 70, Issue 12, 2011, Pages 2152-2154

  Gladman, Dafna D ^a   Thavaneswaran, Arane ^a   Chandran, Vinod ^a   Cook, Richard J ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ARTICLE; CANADA; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENDER; HUMAN; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS;

ADULT; AGE FACTORS; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DISEASE PROGRESSION; EARLY DIAGNOSIS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; PATIENT SELECTION; PROGNOSIS; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 82755197725     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.150938     Document Type: Article

References (20)

1. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
2. Gladman DD. Psoriatic arthritis from Wright's era until today. J Rheumatol Suppl 2009;83:4-8.
3. Gladman DD. Disability and quality of life considerations. Psoriatic arthritis. Gordon GB, Ruderman E, eds. Psoriasis and Psoriatic Arthritis: an Integrated Approach. Heidelberg, Germany: Springer-Verlag, 2005:118-23.
4. Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008;26(5 Suppl 51): S62-5.
5. Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003;42:1460-8. (Pubitemid 37508919)
6. Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-41. (Pubitemid 17042878)
7. Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 2011;50:25-31.
8. Rahman P, Gladman DD, Cook RJ, et al. Radiological assessment in psoriatic arthritis. Br J Rheumatol 1998;37:760-5.
9. Gladman DD, Farewell V, Buskila D, et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990;17:62-4. (Pubitemid 20070571)
10. Siannis F, Farewell VT, Cook RJ, et al. Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis 2006;65:478-81.
11. McCullagh P, Nelder JA. Monographs on statistics and applied probability 37. Generalized Linear Models, 2nd edn. London: Chapman and Hall, 1989.
12. Bruce IN, Gladman DD. Psoriatic arthritis: recognition and management. BioDrugs 1998;9:271-8. (Pubitemid 28189373)
13. Mease PJ, Kivitz AJ, Burch FX, et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004;50:2264-72. (Pubitemid 38924405)
14. Gladman DD, Mease PJ, Ritchlin CT, et al. Adalimumab for long-term treatment of psoriatic arthritis: 48-week data and subanalysis from ADEPT. Arthritis Rheum 2007; 56 :476-88.
15. van der Heijde D, Kavanaugh A, Gladman DD, et al. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum 2007;56:2698-707. (Pubitemid 47237288)
16. Kavanaugh A, van der Heijde D, Gladman D, et al. Golimumab Inhibits Progression of Radiographic Damage in Patients with Psoriatic Arthritis: 52 Week Results From the GO-REVEAL Study. Arthritis Rheum 2009;60:3861.
17. Bond SJ, Farewell VT, Schentag CT, et al. Predictors for radiological damage in psoriatic arthritis: results from a single centre. Ann Rheum Dis 2007;66:370-6. (Pubitemid 46579640)
18. Cresswell L, Chandran V, Farewell VT, et al. Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Ann Rheum Dis 2011;70:305-8.
19. Husted JA, Tom BD, Farewell VT, et al. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 2007;56:840-9. (Pubitemid 46399432)
20. Gladman DD, Farewell VT, Wong K, et al. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998;41:1103-10. (Pubitemid 28265412)